CD80 and neoplasm: There was also no significant correlation between the %T2* change and CD206+CD80− M2 population in the FMX group for either the primary tumor (p = 0.50, Figure S10A), flank tumor (p = 0.11, Figure S10B) or when pooling all tumors (p = 0.89, Figure 5C).